News & Analysis on Clinical Trial Services & Contract Research And Development
A case currently going through the European Court of Justice could have worrying implications for companies that use reformulation and drug delivery as a way to extend the patented lifespan of their drugs.
SkyePharma has completed Phase III testing of a new version of AstraZeneca's asthma drug Pulmicort (budesonide) that does not use ozone-depleting chlorofluorocarbon (CFC) propellants.
Lonza Biologics has licensed rights its proprietary CHOK1SV cell line to Canadian firm Chromos Molecular Systems for a project aimed at making improved mammalian cells for biological syntheses.
A new Sino-American joint venture for manufacturing pharmaceuticals, HBBenda, has started operations in Guangshui, China, after being granted Good Manufacturing Practice (GMP) approval.